BRIEF-Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown In Its Artistry-1 Clinical Trial Of Nemvaleukin

Reuters
2024-11-21
BRIEF-<a href="https://laohu8.com/S/MURA">Mural Oncology</a> Announces Publication Highlighting Promising Clinical Antitumor Activity Shown In Its Artistry-1 Clinical Trial Of Nemvaleukin

Nov 20 (Reuters) - Mural Oncology PLC MURA.O:

  • MURAL ONCOLOGY ANNOUNCES PUBLICATION HIGHLIGHTING PROMISING CLINICAL ANTITUMOR ACTIVITY SHOWN IN ITS ARTISTRY-1 CLINICAL TRIAL OF NEMVALEUKIN, ITS LEAD ENGINEERED FUSION PROTEIN, IN THE JOURNAL FOR IMMUNOTHERAPY OF CANCER

Source text: ID:nGNX1c1yP2

Further company coverage: MURA.O

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10